Evidence map›Paper›PMID 25874038›Full record

ReviewKorean journal of urology2015

Prospects of stem cell treatment in benign urological diseases.

Amjad Alwaal, Ahmed A Hussein, Ching-Shwun Lin, Tom F Lue

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Korean journal of urology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Current status of stem cell therapy in urology.Korean journal of urology · 2015
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amjad AlwaalDepartment of Urology, University of California, San Francisco, CA, USA. ; Department of Urology, King Abdul Aziz University, Jeddah, Saudi Arabia.
Ahmed A HusseinDepartment of Urology, University of California, San Francisco, CA, USA. ; Department of Urology, Cairo University, Cairo, Egypt.
Ching-Shwun LinDepartment of Urology, University of California, San Francisco, CA, USA.
Tom F LueDepartment of Urology, University of California, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cells (SCs) are undifferentiated cells that are capable of self-renewal and differentiation and that therefore contribute to the renewal and repair of tissues. Their capacity for division, differentiation, and tissue regeneration is highly dependent on the surrounding environment. Several preclinical and clinical studies have utilized SCs in urological disorders. In this article, we review the current status of SC use in benign urological diseases (erectile dysfunction, Peyronie disease, infertility, and urinary incontinence), and we summarize the results of the preclinical and clinical trials that have been conducted.

Indexed as

Erectile DysfunctionFemaleHumansMaleOutcome Assessment, Health CareStem Cell TransplantationUrinary IncontinenceErectile dysfunctionInfertilityStem cellsUrinary incontinence

Identifiers

PMID25874038
PMCPMC4392024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.